Literature DB >> 27799548

PTPN22 contributes to exhaustion of T lymphocytes during chronic viral infection.

Christian J Maine1, John R Teijaro1, Kristi Marquardt1, Linda A Sherman2.   

Abstract

The protein encoded by the autoimmune-associated protein tyrosine phosphatase nonreceptor type 22 gene, PTPN22, has wide-ranging effects in immune cells including suppression of T-cell receptor signaling and promoting efficient production of type I interferons (IFN-I) by myeloid cells. Here we show that mice deficient in PTPN22 resist chronic viral infection with lymphocytic choriomeningitis virus clone 13 (LCMV cl13). The numbers and function of viral-specific CD4 T lymphocytes is greatly enhanced, whereas expression of the IFNβ-induced IL-2 repressor, cAMP-responsive element modulator (CREM) is reduced. Reduction of CREM expression in wild-type CD4 T lymphocytes prevents the loss of IL-2 production by CD4 T lymphocytes during infection with LCMV cl13. These findings implicate the IFNβ/CREM/IL-2 axis in regulating T-lymphocyte function during chronic viral infection.

Entities:  

Keywords:  CREM; LCMV; PTPN22; T-cell exhaustion; chronic infection

Mesh:

Substances:

Year:  2016        PMID: 27799548      PMCID: PMC5135306          DOI: 10.1073/pnas.1603738113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  59 in total

1.  Antigen-specific CD4 T-cell help rescues exhausted CD8 T cells during chronic viral infection.

Authors:  Rachael D Aubert; Alice O Kamphorst; Surojit Sarkar; Vaiva Vezys; Sang-Jun Ha; Daniel L Barber; Lilin Ye; Arlene H Sharpe; Gordon J Freeman; Rafi Ahmed
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-12       Impact factor: 11.205

2.  Retroviral vector expression in TCR transgenic CD4⁺ T cells.

Authors:  Youn Soo Choi; Shane Crotty
Journal:  Methods Mol Biol       Date:  2015

3.  Phenotypic and functional profiling of malaria-induced CD8 and CD4 T cells during blood-stage infection with Plasmodium yoelii.

Authors:  Anmol Chandele; Paushali Mukerjee; Gobardhan Das; Rafi Ahmed; Virander S Chauhan
Journal:  Immunology       Date:  2010-10-29       Impact factor: 7.397

4.  PTPN22 alters the development of regulatory T cells in the thymus.

Authors:  Christian J Maine; Emma E Hamilton-Williams; Jocelyn Cheung; Stephanie M Stanford; Nunzio Bottini; Linda S Wicker; Linda A Sherman
Journal:  J Immunol       Date:  2012-04-25       Impact factor: 5.422

5.  Molecular basis of deficient IL-2 production in T cells from patients with systemic lupus erythematosus.

Authors:  E E Solomou; Y T Juang; M F Gourley; G M Kammer; G C Tsokos
Journal:  J Immunol       Date:  2001-03-15       Impact factor: 5.422

6.  Blockade of chronic type I interferon signaling to control persistent LCMV infection.

Authors:  Elizabeth B Wilson; Douglas H Yamada; Heidi Elsaesser; Jonathan Herskovitz; Jane Deng; Genhong Cheng; Bruce J Aronow; Christopher L Karp; David G Brooks
Journal:  Science       Date:  2013-04-12       Impact factor: 47.728

7.  PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells.

Authors:  Erin E West; Hyun-Tak Jin; Ata-Ur Rasheed; Pablo Penaloza-Macmaster; Sang-Jun Ha; Wendy G Tan; Ben Youngblood; Gordon J Freeman; Kendall A Smith; Rafi Ahmed
Journal:  J Clin Invest       Date:  2013-05-15       Impact factor: 14.808

8.  Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired.

Authors:  Mojgan Ahmadzadeh; Laura A Johnson; Bianca Heemskerk; John R Wunderlich; Mark E Dudley; Donald E White; Steven A Rosenberg
Journal:  Blood       Date:  2009-05-07       Impact factor: 22.113

Review 9.  CREM: a master-switch in the transcriptional response to cAMP.

Authors:  M Lamas; L Monaco; E Zazopoulos; E Lalli; K Tamai; L Penna; C Mazzucchelli; F Nantel; N S Foulkes; P Sassone-Corsi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1996-04-29       Impact factor: 6.237

10.  Analysis of successful immune responses in persons infected with hepatitis C virus.

Authors:  F Lechner; D K Wong; P R Dunbar; R Chapman; R T Chung; P Dohrenwend; G Robbins; R Phillips; P Klenerman; B D Walker
Journal:  J Exp Med       Date:  2000-05-01       Impact factor: 14.307

View more
  17 in total

1.  The PTPN22 R263Q polymorphism confers protection against systemic lupus erythematosus and rheumatoid arthritis, while PTPN22 R620W confers susceptibility to Graves' disease in a Mexican population.

Authors:  Daniela Josabeth López-Cano; Daniel Cadena-Sandoval; Olga Beltrán-Ramírez; Rosa Elda Barbosa-Cobos; Fausto Sánchez-Muñoz; Luis Manuel Amezcua-Guerra; Yaneli Juárez-Vicuña; María Concepción Aguilera-Cartas; José Moreno; Jesús Bautista-Olvera; Guillermo Valencia-Pacheco; Ricardo F López-Villanueva; Julian Ramírez-Bello
Journal:  Inflamm Res       Date:  2017-05-12       Impact factor: 4.575

Review 2.  Regulation of autoimmune and anti-tumour T-cell responses by PTPN22.

Authors:  Rebecca J Brownlie; Rose Zamoyska; Robert J Salmond
Journal:  Immunology       Date:  2018-04-16       Impact factor: 7.397

3.  Efficient CRISPR/Cas9 Disruption of Autoimmune-Associated Genes Reveals Key Signaling Programs in Primary Human T Cells.

Authors:  Warren Anderson; Jerill Thorpe; S Alice Long; David J Rawlings
Journal:  J Immunol       Date:  2019-11-13       Impact factor: 5.422

4.  Proautoimmune Allele of Tyrosine Phosphatase, PTPN22, Enhances Tumor Immunity.

Authors:  Robin C Orozco; Kristi Marquardt; Kerri Mowen; Linda A Sherman
Journal:  J Immunol       Date:  2021-08-20       Impact factor: 5.422

Review 5.  PTPN22: structure, function, and developments in inhibitor discovery with applications for immunotherapy.

Authors:  Brenson A Jassim; Jianping Lin; Zhong-Yin Zhang
Journal:  Expert Opin Drug Discov       Date:  2022-06-07       Impact factor: 7.050

Review 6.  Regulation of activated T cell survival in rheumatic autoimmune diseases.

Authors:  Florencia Rosetti; Iris K Madera-Salcedo; Noé Rodríguez-Rodríguez; José C Crispín
Journal:  Nat Rev Rheumatol       Date:  2022-01-24       Impact factor: 32.286

Review 7.  CD4 T-Cell Exhaustion: Does It Exist and What Are Its Roles in Cancer?

Authors:  Alexandra M Miggelbrink; Joshua D Jackson; Selena J Lorrey; Ethan S Srinivasan; Jessica Waibl-Polania; Daniel S Wilkinson; Peter E Fecci
Journal:  Clin Cancer Res       Date:  2021-06-14       Impact factor: 12.531

8.  Extrinsic Protein Tyrosine Phosphatase Non-Receptor 22 Signals Contribute to CD8 T Cell Exhaustion and Promote Persistence of Chronic Lymphocytic Choriomeningitis Virus Infection.

Authors:  Tatiana Jofra; Giuseppe Galvani; Mirela Kuka; Roberta Di Fonte; Bechara G Mfarrej; Matteo Iannacone; Shahram Salek-Ardakani; Manuela Battaglia; Georgia Fousteri
Journal:  Front Immunol       Date:  2017-07-12       Impact factor: 7.561

9.  Restoration of the type I IFN-IL-1 balance through targeted blockade of PTGER4 inhibits autoimmunity in NOD mice.

Authors:  M Jubayer Rahman; Kameron B Rodrigues; Juan A Quiel; Yi Liu; Vipul Bhargava; Yongge Zhao; Chie Hotta-Iwamura; Han-Yu Shih; Annie W Lau-Kilby; Allison Mw Malloy; Timothy W Thoner; Kristin V Tarbell
Journal:  JCI Insight       Date:  2018-02-08

10.  Fresh Ideas, Foundational Experiments (FIFE): Immunology and Diabetes 2016 FIFE Symposium.

Authors:  Isobel C Mouat; Zachary J Morse; Virginie S E Jean-Baptiste; Jessica R Allanach; Marc S Horwitz
Journal:  Front Endocrinol (Lausanne)       Date:  2017-09-19       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.